EVENITY
Google image searchProduct monograph
Active ingredient
romosozumab, 105 MG/1.17 ML
DIN: 02489597
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: PREFILLED SYRINGE
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 12-AUG-2019
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BX — Other drugs affecting bone structure and mineralization (ATC, ATC/DDD)
- M05BX06 — ROMOSOZUMAB (ATC/DDD)
